Sino Biological,Inc. (SHE:301047)

China flag China · Delayed Price · Currency is CNY
70.94
+0.84 (1.20%)
At close: Apr 29, 2026
18.13%
Market Cap 8.53B
Revenue (ttm) 699.56M
Net Income (ttm) 147.74M
Shares Out 121.64M
EPS (ttm) 1.21
PE Ratio 57.71
Forward PE 48.34
Dividend 5.20 (7.42%)
Ex-Dividend Date Sep 22, 2025
Volume 956,593
Average Volume 1,085,391
Open 70.00
Previous Close 70.10
Day's Range 69.75 - 71.40
52-Week Range 59.87 - 85.00
Beta 0.91
RSI 42.92
Earnings Date Apr 14, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 1,021
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301047
Full Company Profile

Financial Performance

In 2025, Sino Biological,Inc.'s revenue was 699.56 million, an increase of 14.00% compared to the previous year's 613.67 million. Earnings were 147.74 million, an increase of 21.17%.

Financial Statements

News

There is no news available yet.